Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.
An aging population and latent effects from exposure to carcinogens will likely augment the current trend of increased incidence of urinary bladder cancer. Intravesical antineoplastic therapy is a common treatment for urinary bladder cancer. Transurethral resection of bladder tumors often is followed immediately by the instillation of an antineoplastic agent in the operating room or postanesthesia care unit. Oncology nurses, who have a unique knowledge of safe handling and patient care, can improve staff safety and patient outcomes in several areas of healthcare organizations, as well as reduce the mortality and morbidity of urinary bladder cancer by learning more about the disease and intravesical antineoplastic therapy.
Washburn
Donna J
DJ
Centra Health Inc., Lynchburg, VA, USA. donna.washburn@centrahealth.com
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D016903:Drug Monitoring; D006801:Humans; D007322:Instillation, Drug; D008403:Mass Screening; D024802:Nurse's Role; D009730:Nursing Assessment; D009859:Oncology Nursing / Q000379:methods*; D010351:Patient Discharge; D010353:Patient Education as Topic; D011182:Postoperative Care / Q000379:methods / Q000451:nursing; D017751:Safety Management / Q000458:organization & administration; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000601:surgery; D014546:Urinary Catheterization / Q000379:methods / Q000451:nursing
D000970:Antineoplastic Agents